文献速递神经肿瘤功能神经外科

岛叶胶质瘤:拉丁美洲中心的经验及与外科管理和预后相关变量的评估

Insular Gliomas. Experience in a Latin American Center and Assessment of Variables Related to Surgical Management and Prognosis.
PubMed 文献 · World Neurosurg · 2024-09-10

该回顾性单中心分析研究纳入2010至2023年间在阿根廷三级中心由同一术者手术的岛叶胶质瘤患者,分析人口学、临床、影像学特征及手术变量与术后结果和预后的关系,采用多变量回归分析。结果显示低级别胶质瘤占66.1%,切除程度>90%者占62.3%,低级别与高级别胶质瘤的生存和复发差异明显。作者认为岛叶胶质瘤手术复杂,需充分的术前和术中评估以实现最大安全切除。

要点

  • 低级别胶质瘤占66.1%,切除程度>90%者占62.3%,全切除占27%。
  • 低级别胶质瘤2年生存100%、4年总生存92%;高级别胶质瘤2年生存46%、4年总生存15.4%。
  • 作者认为充分的解剖理解、影像分析、清醒开颅和皮质及皮质下定位对实现最大安全切除至关重要。

核心结论

  • 作者认为岛叶胶质瘤手术复杂,需充分的术前和术中评估以实现最大安全切除并降低发病率,从而获得更好的功能和肿瘤学结果。

研究设计与样本

  • 回顾性、单中心、分析性研究,纳入2010至2023年间在阿根廷三级中心由同一术者手术的岛叶胶质瘤患者83例,采用多变量回归分析。

主要发现

  • 共纳入53例患者(54%为男性),平均随访40.7个月,手术时平均年龄41岁(范围21-73岁),低级别胶质瘤占66.1%。
  • 大多数病例以癫痫发作为首发症状,64.2%的患者存在肿瘤经岛叶向颞叶和/或额叶延伸。
  • 切除程度>90%者占62.3%(全切除占27%),平均切除体积为89.4%;47%的患者行清醒开颅,24%行术中磁共振成像。
  • 44%的患者出现复发,平均无进展生存期为31个月(低级别胶质瘤42个月,高级别胶质瘤10个月),9例患者再次手术。
  • 2年时低级别胶质瘤生存率为100%、高级别胶质瘤为46%;4年总生存率低级别胶质瘤为92%、高级别胶质瘤为15.4%。

临床怎么用

  • 作者认为充分的解剖理解、影像学分析、清醒开颅以及皮质和皮质下定位对实现最大安全切除至关重要。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To describe our experience in the resection of gliomas involving the insula and analyze the variables implicated in the management and prognosis of these tumors. METHODS: This retrospective, single-center, analytic study included a cohort of 83 patients who underwent surgery for insular gliomas by the same surgeon in a third-level Argentine center, in the period between 2010 and 2023. We analyzed the population's demographic, clinical, and radiologic features and surgical variables associated with postoperative results and prognosis using multivariate regression analysis. RESULTS: A total of 53 patients (54% men) were included, with a mean follow-up of 40.7 months. The mean age at surgery was 41 years (range, 21-73) and 66.1% corresponded to low-grade gliomas (LGGs). Seizures were the initial symptom in most cases. There was evidence of tumor extension over the insula to the temporal or/and frontal lobe in 64.2% of patients. An extent of resection >90% was achieved in 62.3% of cases (27% of gross total resection), with an average resected volume of 89.4%. Awake craniotomy was indicated in 47% of patients and intraoperative magnetic resonance imaging was performed in 24%. Recurrence was observed in 44% of patients, with a mean progression-free survival of 31 months (42 months in LGG and 10 months in high-grade glioma [HGG]). Nine patients underwent reoperation. By the time of 2 years, survival was 100% for LGG and 46% for HGG, whereas 4-year overall survival was 92% for patients with LGG and 15.4% for those with HGG. CONCLUSIONS: Surgery for insular gliomas is a complex task that needs to be managed with adequate preoperative and intraoperative assessment to achieve maximum safe resection with low morbidity for better functional and oncologic outcomes. Adequate anatomic understanding, radiologic analysis, awake craniotomy, and cortical and subcortical mapping are paramount to pursue this aim.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Ruella ME, Caffaratti G, Villamil F, et al. Insular Gliomas. Experience in a Latin American Center and Assessment of Variables Related to Surgical Management and Prognosis. World Neurosurg. 2024. PMID: 39265939. doi:10.1016/j.wneu.2024.09.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。